Wells Fargo
MRVI icon

Wells Fargo’s Maravai LifeSciences MRVI Stock Holding History

Wells Fargo’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Sell
41,791
-81,243
-66% -$275K ﹤0.01% 5014
2025
Q4 		$400K Buy
123,034
+38,743
+46% +$130K ﹤0.01% 4644
2025
Q3 		$242K Buy
84,291
+5,054
+6% +$12.9K ﹤0.01% 4826
2025
Q2 		$191K Buy
79,237
+25,388
+47% +$53.4K ﹤0.01% 4800
2025
Q1 		$119K Buy
53,849
+1,164
+2% +$4.6K ﹤0.01% 5009
2024
Q4 		$287K Buy
52,685
+15,001
+40% +$96.5K ﹤0.01% 4562
2024
Q3 		$313K Sell
37,684
-1,786
-5% -$15.4K ﹤0.01% 4287
2024
Q2 		$283K Buy
39,470
+31,176
+376% +$269K ﹤0.01% 4283
2024
Q1 		$71.9K Sell
8,294
-1,209
-13% -$8.18K ﹤0.01% 5080
2023
Q4 		$62.2K Sell
9,503
-20,535
-68% -$133K ﹤0.01% 5188
2023
Q3 		$300K Sell
30,038
-220
-0.7% -$2.42K ﹤0.01% 4096
2023
Q2 		$376K Sell
30,258
-2,308
-7% -$31.2K ﹤0.01% 4150
2023
Q1 		$456K Buy
32,566
+188
+0.6% +$2.7K ﹤0.01% 3911
2022
Q4 		$463K Buy
32,378
+3,925
+14% +$61.8K ﹤0.01% 3688
2022
Q3 		$727K Buy
28,453
+233
+0.8% +$5.85K ﹤0.01% 3443
2022
Q2 		$801K Sell
28,220
-34,130
-55% -$1.08M ﹤0.01% 3436
2022
Q1 		$2.2M Sell
62,350
-43,900
-41% -$1.47M ﹤0.01% 3208
2021
Q4 		$4.45M Sell
106,250
-220,542
-67% -$8.93M ﹤0.01% 2691
2021
Q3 		$16M Buy
326,792
+234,785
+255% +$11.5M ﹤0.01% 1833
2021
Q2 		$3.84M Sell
92,007
-5,293
-5% -$205K ﹤0.01% 3101
2021
Q1 		$3.47M Buy
97,300
+30,279
+45% +$1M ﹤0.01% 3197
2020
Q4 		$1.88M Buy
+67,021
New +$1.87M ﹤0.01% 3544

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's MRVI Position: Q1 2026 in Review

Wells Fargo reduced its Maravai LifeSciences (MRVI) stake by 66% in Q1 2026, selling an estimated $275K and leaving 41,791 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #5014.

Wells Fargo first reported a position in MRVI in Q4 2020 and has held it in 22 quarters since. The position peaked at $16M in Q3 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Wells Fargo held 41,791 shares of Maravai LifeSciences worth $118K as of Q1 2026.
  • Wells Fargo sold 81,243 Maravai LifeSciences shares in Q1 2026, an estimated $275K.
  • Maravai LifeSciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5014 holding.
  • Wells Fargo first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 22 quarters since.
  • Wells Fargo's Maravai LifeSciences position peaked at $16M in Q3 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.